Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BACK IMAC	$0.07 -1.3%	$0.07	$0.03 ▼ $1.82	$145K	2.19	599,568 shs	31,230 shs
BTTX Better Therapeutics	$0.00	$0.00	$0.00 ▼ $0.00	$5K	0.97	15,272 shs	10,311 shs
NIVF NewGenIvf Group	$1.88 +0.5%	$3.00	$1.62 ▼ $3,280.00	$1.62M	-0.09	211,140 shs	22,331 shs
OTRK Ontrak	$0.09 +20.6%	$0.46	$0.05 ▼ $0.12	$422K	1.97	279,981 shs	105,730 shs

(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BACK IMAC	-1.25%	-10.79%	+18.50%	+93.73%	-95.94%
BTTX Better Therapeutics	0.00%	0.00%	0.00%	0.00%	0.00%
NIVF NewGenIvf Group	+3.31%	+5.95%	-28.09%	-82.92%	-99.80%
OTRK Ontrak	-22.53%	-2.62%	-86.59%	-95.48%	-97.93%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BACK IMAC	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
BTTX Better Therapeutics	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
NIVF NewGenIvf Group	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
OTRK Ontrak	2.6864 of 5 stars	3.5	2.0	0.0	0.0	3.8	0.0	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BACK IMAC	0.00	N/A	N/A	N/A
BTTX Better Therapeutics	0.00	N/A	N/A	N/A
NIVF NewGenIvf Group	0.00	N/A	N/A	N/A
OTRK Ontrak	3.00	Buy	$3.00	3,429.41% Upside

Current Analyst Ratings Breakdown

Latest OTRK, NIVF, BACK, and BTTX Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
7/9/2025	OTRK Ontrak	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$4.00 ➝ $3.00

(Data available from 8/28/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BACK IMAC	$72.05K	2.02	N/A	N/A	($0.66) per share	-0.11
BTTX Better Therapeutics	N/A	N/A	N/A	N/A	N/A	N/A
NIVF NewGenIvf Group	$5.43M	0.30	N/A	N/A	($146.02) per share	-0.01
OTRK Ontrak	$10.18M	0.04	N/A	N/A	$2.34 per share	0.04

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BACK IMAC	-$9.42M	N/A	0.00	∞	N/A	N/A	N/A	-325.44%	11/3/2025 (Estimated)
BTTX Better Therapeutics	-$39.76M	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
NIVF NewGenIvf Group	-$520K	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
OTRK Ontrak	-$25.49M	-$15.81	N/A	N/A	N/A	-274.20%	-269.88%	-128.35%	9/4/2025 (Estimated)

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BACK IMAC	N/A	N/A	N/A	N/A	N/A
BTTX Better Therapeutics	N/A	N/A	N/A	N/A	N/A
NIVF NewGenIvf Group	N/A	N/A	N/A	N/A	N/A
OTRK Ontrak	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BACK IMAC	N/A	0.08	0.08
BTTX Better Therapeutics	N/A	N/A	N/A
NIVF NewGenIvf Group	N/A	1.17	1.14
OTRK Ontrak	0.54	0.72	0.72

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BACK IMAC	5.84%
BTTX Better Therapeutics	34.00%
NIVF NewGenIvf Group	66.24%
OTRK Ontrak	12.95%

Insider Ownership

Company	Insider Ownership
BACK IMAC	12.26%
BTTX Better Therapeutics	51.40%
NIVF NewGenIvf Group	31.80%
OTRK Ontrak	1.90%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BACK IMAC	180	2.07 million	1.82 million	Not Optionable
BTTX Better Therapeutics	40	49.86 million	24.23 million	Optionable
NIVF NewGenIvf Group	N/A	860,000	590,000	N/A
OTRK Ontrak	250	4.22 million	4.14 million	No Data

OTRK, NIVF, BACK, and BTTX Headlines

Recent News About These Companies

Will Ontrak, Inc. (OTRK) Report Negative Q2 Earnings? What You Should Know

August 7, 2025 | zacks.com

Ontrak (OTRK) Upgraded to Buy: Here's Why - Yahoo Finance

July 13, 2025 | finance.yahoo.com

Ontrak (OTRK) Upgraded to Buy: Here's Why

July 11, 2025 | zacks.com

Here's Why Ontrak (OTRK) Could be Great Choice for a Bottom Fisher

July 11, 2025 | zacks.com

Ontrak Completes $3.24 Million Public Offering

July 3, 2025 | msn.com

Ontrak Health Announces Pricing of $4 Million Public Offering

June 27, 2025 | businesswire.com

Milken protege Peizer gets 3-1/2 years prison for insider trading, plans appeal

June 23, 2025 | reuters.com

Ontrak Inc (OTRK) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic Growth ...

May 21, 2025 | finance.yahoo.com

Ontrak Health to Report 2025 First Quarter Financial Results on May 20, 2025

May 19, 2025 | businesswire.com

Ontrak reports Q4 EPS ($9.29) vs. ($4.02) last year

April 15, 2025 | markets.businessinsider.com

Ontrak, Inc. (NASDAQ:OTRK) Q4 2024 Earnings Call Transcript

April 15, 2025 | msn.com

Ontrak Health to Report 2024 Fourth Quarter Financial Results on April 14, 2025

April 10, 2025 | businesswire.com

Ontrak Secures Medicaid Provider Designation in Two New States, Enhancing Direct Service Delivery Capabilities

April 4, 2025 | finance.yahoo.com

Ontrak secures Medicaid provider designation in two new states

April 4, 2025 | markets.businessinsider.com

Ontrak extends strategic partnership with Sentara Health Plans in Virginia

February 19, 2025 | markets.businessinsider.com

Ontrak Health and Sentara Health Plans Execute Three-year Contract Extension Following Several Expansions

February 19, 2025 | finance.yahoo.com

Ontrak Inc. (OTRK) Partners with Intermountain Health to Deliver AI-Powered Behavioral Health Solutions

January 14, 2025 | msn.com

Ontrak, Inc. (OTRK) Reports Q3 Loss, Lags Revenue Estimates

November 13, 2024 | zacks.com

Ontrak Health Announces 2024 Third Quarter Financial Results

November 13, 2024 | businesswire.com

Ontrak, Inc. (OTRK) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

November 6, 2024 | zacks.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

OTRK, NIVF, BACK, and BTTX Company Descriptions

IMAC NASDAQ:BACK

$0.07 0.00 (-1.27%)

As of 02:43 PM Eastern

IMAC Holdings, Inc. owns and manages innovative medical advancements and care regeneration centers, and backspace clinics in the United States. The company's outpatient medical clinics provide regenerative, orthopedic, and minimally invasive procedures and therapies to patients with sports injuries, ligament and tendon damage, and other related soft tissue conditions, as well as back, knee, and joint pains. It also provides medical treatments, regenerative, spinal decompression, chiropractic manipulation, and physical medicine and therapy. IMAC Holdings, Inc. was founded in 2000 and is headquartered in Franklin, Tennessee.

Better Therapeutics NASDAQ:BTTX

$0.0001 0.00 (0.00%)

As of 08/27/2025 09:55 AM Eastern

Better Therapeutics, Inc., a prescription digital therapeutics company, develops a form of cognitive behavioral therapy to address the causes of cardiometabolic diseases. The company's lead product candidate is BT-001, an investigational PDT platform to treat type 2 diabetes. It also develops software-based prescription digital therapeutics platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions. In addition, the company's clinical development candidates are intended to treat cardiometabolic diseases, including type 2 diabetes, hypertension, hyperlipidemia, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, and chronic kidney disease. Its product pipeline also includes BT-002, which intends glycemic control for hypertension; BT-003 to reduce LDL cholesterol in patients with hyperlipidemia; and BT-004, which intends to explore the impact of treatment on liver health in patients with non-alcoholic steatohepatitis/non-alcoholic fatty liver disease. The company was founded in 2015 and is headquartered in San Francisco, California.

NewGenIvf Group NASDAQ:NIVF

$1.88 +0.01 (+0.53%)

Closing price 03:57 PM Eastern

Extended Trading

$1.88 0.00 (-0.27%)

As of 07:46 PM Eastern

NewGenIVF Group Ltd. operates as an assisted reproductive services provider. It focuses on providing fertility treatments to fulfil the dreams of building families. The firm offers in-vitro fertilization treatment service, comprising traditional IVF and egg donation, and surrogacy and ancillary caring services. The company was founded by Siu Wing Fung and Fong Hei Yue on January 16, 2019 and is headquartered in Bangkok, Thailand.

Ontrak NASDAQ:OTRK

$0.08 +0.01 (+20.57%)

As of 03:57 PM Eastern

Ontrak, Inc. operates as an artificial intelligence powered, telehealth-enabled, and virtualized healthcare company that provides in-person services to third-party payors in the United States. Its technology-enabled platform predicts people whose chronic disease will improve with behavior change, recommends effective care pathways that people are willing to follow, and engages and guides them to and through the care they need. The company's technology enabled OnTrak program provides healthcare solutions to members with behavioral conditions that cause or exacerbate chronic medical conditions, such as diabetes, hypertension, coronary artery disease, chronic obstructive pulmonary disease, and congestive heart failure. The OnTrak integrates evidence-based psychosocial and medical interventions delivered in-person or via telehealth along with care coaching and in-market community care coordinators, who address the social and environmental determinants of health. The company was formerly known as Catasys, Inc. and changed its name to Ontrak, Inc. in July 2020. Ontrak, Inc. was incorporated in 2003 and is headquartered in Miami, Florida.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time